Low-level laser therapy (LLLT) reduces the COX-2 mRNA expression in both subplantar and total brain tissues in the model of peripheral inflammation induced by administration of carrageenan
- 16 February 2014
- journal article
- research article
- Published by Springer Nature in Lasers in Medical Science
- Vol. 29 (4) , 1397-1403
Abstract
In the classical model of edema formation and hyperalgesia induced by carrageenan administration in rat paw, the increase in prostaglandin E2 (PGE2) production in the central nervous system (CNS) contributes to the severity of the inflammatory and pain responses. Prostaglandins are generated by the cyclooxygenase (COX). There are two distinct COX isoforms, COX-1 and COX-2. In inflammatory tissues, COX-2 is greatly expressed producing proinflammatory prostaglandins (PGs). Low-level laser therapy (LLLT) has been used in the treatment of inflammatory pathologies, reducing both pain and acute inflammatory process. Herein we studied the effect of LLLT on both COX-2 and COX-1 messenger RNA (mRNA) expression in either subplantar or brain tissues taken from rats treated with carrageenan. The experiment was designed as follows: A1 (saline), A2 (carrageenan—0.5 mg/paw), A3 (carrageenan—0.5 mg/paw + LLLT), A4 (carrageenan—1.0 mg/paw), and A5 (carrageenan—1.0 mg/paw + LLLT). Animals from the A3 and A5 groups were irradiated at 1 h after carrageenan administration, using a diode laser with an output power of 30 mW and a wavelength of 660 nm. The laser beam covered an area of 0.785 cm2, resulting in an energy dosage of 7.5 J/cm2. Both COX-2 and COX-1 mRNAs were measured by RT-PCR. Six hours after carrageenan administration, COX-2 mRNA expression was significantly increased both in the subplantar (2.2–4.1-fold) and total brain (8.65–13.79-fold) tissues. COX-1 mRNA expression was not changed. LLLT (7.5 J/cm2) reduced significantly the COX-2 mRNA expression both in the subplantar (~2.5-fold) and brain (4.84–9.67-fold) tissues. The results show that LLLT is able to reduce COX-2 mRNA expression. It is possible that the mechanism of LLLT decreasing hyperalgesia is also related to its effect in reducing the COX-2 expression in the CNS.Keywords
This publication has 39 references indexed in Scilit:
- Use of low intensity laser treatment in neuropathic pain refractory to clinical treatment in amputation stumpsInternational Journal of General Medicine, 2012
- Low‐level laser therapy in collagenase‐induced Achilles tendinitis in rats: Analyses of biochemical and biomechanical aspectsJournal of Orthopaedic Research, 2012
- Effects of COX inhibition on experimental pain and hyperalgesia during and after remifentanil infusion in humansPain, 2011
- Intraplantar‐injected ceramide in rats induces hyperalgesia through an NF‐κB‐ and p38 kinase‐dependent cyclooxygenase 2/prostaglandin E 2 pathwayThe FASEB Journal, 2011
- Effect of endotoxin treatment on the expression and localization of spinal cyclooxygenase, prostaglandin synthases, and PGD2receptorsJournal of Neurochemistry, 2007
- Systemic inflammation induces COX-2 mediated prostaglandin D2 biosynthesis in mice spinal cordNeuropharmacology, 2006
- A randomised, placebo controlled trial of low level laser therapy for activated Achilles tendinitis with microdialysis measurement of peritendinous prostaglandin E2 concentrationsBritish Journal of Sports Medicine, 2005
- Carrageenan-induced Paw Edema in Rat Elicits a Predominant Prostaglandin E2 (PGE2) Response in the Central Nervous System Associated with the Induction of Microsomal PGE2 Synthase-1Journal of Biological Chemistry, 2004
- Cloning Two Isoforms of Rat Cyclooxygenase: Differential Regulation of Their ExpressionArchives of Biochemistry and Biophysics, 1993
- Human cyclooxygenase-2 cDNA.Proceedings of the National Academy of Sciences, 1992